Logo

Crossref


1. Impact of Impaired Renal Function on the Efficacy and Safety of Second‐Line Tyrosine Kinase Inhibitor Therapy After First‐Line Immuno‐Oncology Combination Therapy in Metastatic Renal Cell Carcinoma: A Japanese Multicenter Retrospective Study

- Naoki Fujita

- Yuto Matsushita

- Takahiro Kojima

- Yukari Bando

- Takahiro Osawa

- Tomokazu Sazuka

- Keisuke Goto

- Kazuyuki Numakura

- Kazutoshi Yamana

- Shuya Kandori

- Yoshihide Kawasaki

- Takuma Kato

- Makito Miyake

- Kazutoshi Fujita

- Kosuke Ueda

- Hajime Tanaka

- Ryotaro Tomida

- Hiroshi Kitamura

- Hideaki Miyake

- Shingo Hakakeyama